Added to YB: 2024-07-01
Pitch date: 2024-07-01
MREO [bullish]
Mereo BioPharma Group plc
-39.89%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
Market Cap
$281.6M
Pitch Price
$3.61
Price Target
4.50 (+107%)
Dividend
N/A
EV/EBITDA
-5.22
P/E
-5.60
EV/Sales
452.15
Sector
Biotechnology
Category
special_situation
Raging Bull Investments Stock Idea - Mereo BioPharma Group plc
MREO: Lead asset setrusumab shows promise; oversubscribed ATM at $3.99 w/ smart money participation incl. Rubric Capital (15%+ ownership, 50% board control). Alvelestat likely partnered/sold within month. Recent dip from $4.50 highs due to technicals/sector flows. Expect rebound; current $3.60 likely low. Insider holding 2yrs, CB <$1, trimming on upside.
Read full article (1 min)